ALEN's Profile
Displaying 1-50 of 236 result(s).
Recent Articles
- Impinj Experiences a 22% Surge Following Impressive Q2 Results
- Federal Reserve Decision Sparks Diverse Market Reactions
- SPIE Reports Strong 2025 Half-Year Results with Growth and M&A
- JCDecaux Reports Strong Half-Year 2025 Results with Digital Growth
- EfTEN Real Estate Fund Delivers Strong Q2 Results in 2025
- ING Reports Impressive 2Q2025 Financial Performance Growth
- AS Ekspress Grupp Reports Growth Amid Economic Challenges
- Crédit Agricole S.A.'s Strong Growth and Future Plans Unveiled
- Ipsen's Strong Half-Year Performance Leads to Positive Guidance
- Syensqo Announces Launch of New Share Buyback Tranche
- Corbion's Impressive H1 2025 Results Showcase Growth
- Bekaert's Upcoming Share Buyback Program and Insights
- Pharming Group's Financial Upsurge: Q2 Highlights and Future Outlook
- Clariant Q2 2025: Profit Margins Rise Amid Market Challenges
- Ontex Delivers Mixed Results Amid Market Challenges and Changes
- Arcadis Reports Strong Q2 and Half Year 2025 Performance
- dsm-firmenich Showcases Robust H1 2025 Performance and Vision
- AS Ekspress Grupp Reports Positive Growth Amid Economic Pressures
- SCOR Reports Strong Q2 2025 Financial Performance with EUR 226M Gain
- Empowering Youth Against Corruption: ICAC's Landmark Program
- Cyberattacks Continue to Surge: Insights from Semperis Study
- Renault SA Announces 2025 H1 Financial Report Availability
- SCOR Reports Impressive Second Quarter Results with EUR 226M Income
- Ipsen's Robust Half-Year Performance and Optimistic Outlook
- Ontex's Strategic Shift Amidst H1 Revenue Challenges
- Syensqo Reports Strong Q2 Performance Amid Challenges
- argenx Achieves Milestones in 2025: Q2 Financial Highlights
- dsm-firmenich Achieves Strong Growth in H1 2025 Results
- Arcadis Reports Strong Q2 and Half-Year Results for 2025
- Clariant's Q2 2025: Resilient Profitability Amidst Challenges
- Pharming Group Achieves Impressive Revenue Growth in 2025
- Fagron Reports Impressive H1 Growth, Expands Market Presence
- Corbion's 2025 Half-Year Results Exceed Expectations
- Renault Group’s Strong Fundamentals Fuel Growth in Second Half
- Crédit Agricole's Robust Performance in 2025 Revealed
- SPIE Achieves Record-High H1 Earnings and Robust Growth Prospects
- JCDecaux Reports Strong Half-Year 2025 Financial Performance
- ING's 2Q2025 Results Show Strong Growth Amid Challenges
- Societe Generale Reports Exceptional Q2 and H1 2025 Financial Results
- Societe Generale's Impressive H1 2025 Financial Results
- Amcor's Upcoming Fiscal Quarter Results Announcement Details
- Meta Platforms Pursues External Funding to Boost AI Initiatives
- Metalpha Achieves Record Growth and Profits in 2025 Fiscal Year
- Metalpha Achieves Remarkable Growth and Profit Amid Digital Trends
- Trump's New Trade Strategy: Fostering Ties with Pakistan
- Kelso Technologies Inc. Announces Positive Financial Trends
- Caliber Announces Earnings Call and Financial Update Plans
- Kelso Technologies Inc. Reports Positive Q2 Financials and Future Outlook
- BioArctic's Lecanemab Shows Long-Term Efficacy and Safety
- BioArctic's Lecanemab: Demonstrating Sustained Efficacy
